ABSTRACT
INTRODUCTION
Depression has displayed an increasing trend in recent years. Pregnancy increases the chance of developing depression, namely, postpartum depression (PPD). From pregnancy and childbirth to postpartum, women encounter not only enormous physiological changes but also great psychological impacts. The prevalence rates of PPD are approximately 13.8%-19.8% in the USA [1] . and approximately 11.6%-25% in other countries [2] [3] [4] . Studies in Taiwan have demonstrated that 36.3%-42.6% of pregnant women in the Taiwan area have PPD symptoms [5] [6] [7] . Therefore, the chance of developing PPD is high for women in Taiwan, and this problem requires urgent attention. In the serial editions of Diagnostic and Statistical Manual of Mental Disorders (including DSM-III, DSM-III-R, DSM-IV, DSM-IV-TR, and DSM-5) noted that PPD is defined as the onset of mood disorders starting at postpartum 4 weeks. At least 5 symptoms appear every day: depressed mood, obvious lack of interest in usual activities, a decrease or increase in body weight, insomnia or excessive sleep, slow action or
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increased activities due to uneasiness, fatigue or decreased energy, feelings of worthlessness or guilt, diminished abilities of thinking or concentration, and occurrence of thoughts of suicide. These symptoms persist for more than two weeks [8, 9] . Some scholars consider that in addition to the mental illness diagnosis and the presentation of symptoms described in the statistical manual, PPD should also cover self-consciousness of being incapable of the roles, functions, and responsibilities of motherhood, feeling guilty, using more invasive or negative methods in child-rearing (even having thoughts and behaviors of hurting the child when having problems with one's parenting style after birth), changes in the spousal relationship, and the inability to concentrate on routine matters [10] [11] [12] [13] . Therefore, identifying methods to reduce the development of PPD is very important.
Studies on PPD have increased in number in the past twenty to thirty years, with most studies focusing on risk factors. A few studies have noted that poor postpartum sleep quality can easily increase the risk of PPD [14, 15] . Sleep troubles in pregnant women not only affect their ability to fulfill their multiple postpartum roles but also negatively influence the development of the parent-child relationship [16, 17] . Current PPD studies in Taiwan mainly focus on nursing care; most studies have investigated the effects of PPD on the quality of life of women from psychological, family, and social perspectives [18] [19] [20] . Although numerous studies on sleep quality in Taiwan have been reported, few studies have investigated sleep disorders (SD) using pregnant women as the study subjects.
Currently, few reports on sleep assessment targeting pregnant women during pregnancy exist, and no systemic studies have assessed the association between SD and PPD. Therefore, we used the National Health Insurance Research Database (NHIRD) of Taiwan to perform a follow-up study on whether prenatal SD can increase the development of PPD.
RESULTS
Our study presents that there is no Statistical significance in age, number of births, comorbidities and insured premium both in subjects and control groups. (data not shown). Figure 1 presents the flowchart for the study sample selection (inclusion and exclusion), follow-up results and the cumulative risks of developing PPD in these two groups (pregnant women with/without SD). Among 1 million individuals, 980,157 had medical records (outpatient, emergency, or inpatient). In total, 20,140 pregnant women with SD were identified. After employing the exclusion conditions (10,302 were excluded), a total of 9,838 pregnant women with SD (19,676 controls were selected using the 1:2 ratio) were included in this study. Of these women, 0.20% developed PPD (20/9,838 people). The percentage of women who developed PPD in the control group (pregnant women without SD) was 0.05% (10/19,676 people). The difference between these two groups reached significance (log-rank P < 0.001). Thus, the chance (i.e., risk) of developing PPD in pregnant women with SD was significantly increased compared with pregnant women without SD (Figure 2) . Table 1 presents the distribution of the basic characteristics of the 29,514 cases overall (subject group: 9,838 pregnant women with SD; control group: 19,676 pregnant women without SD) at the follow-up endpoint. The percentage of women who developed PPD in the subject group was significantly increased compared with the control group (0.20% vs. 0.05%; P < 0.001).
The percentages of the development of comorbidities, including hypertension (6.31% vs. 3.25%; P < 0.001), DM (4.66% vs. 2.73%; P < 0.001), hyperlipidemia (2.07% vs. 0.80%; P < 0.001), COPD (3.87% vs. 0.96%; P < 0.001), IHD (2.66% vs. 1.65%; P < 0.001), CHD (0.61% vs. 0.40%; P = 0.009), stroke (2.08% vs. 0.86%; P < 0.001), anxiety (2.22% vs. 1.89%; P = 0.032), depression (3.89% vs. 0.91%; P < 0.001), and obesity (0.21% vs. 0.07%; P < 0.001) in the subject group were significantly increased compared with the control group. The percentage of individuals in the subject group who developed PPD in autumn (29.55% vs. 25.99%) was significantly increased compared with the control group (P < 0.001). The percentages of level 3 (9.98% vs. 8.58%) and level 4 (18.14% vs. 12.52%) urbanization of residence in the subject group were increased compared with the control group (P < 0.001). Table 2 lists the univariate and multivariate analysis results on the influencing factors of PPD. After comorbidity, season, urbanization level, and insured premium (income) were controlled, the chance (risk) of developing PPD in pregnant women with SD was 5.359-fold (P < 0.001) increased compared with the control group (pregnant women without SD).
The chances (risks) of developing PPD in pregnant women at the ages of ≤ 20 years, 21-30 years, 31-34 years, 35-37 years, and 38-40 years were 7.692-fold (P < 0.001), 3.231-fold (P < 0.001), 2.923-fold (P < 0.001), 2.538-fold (P < 0.001), and 1.923-fold (P < 0.001) increased compared with those ≥ 41 years. In addition, the chance (risk) of developing PPD in pregnant women with their first-time birth was 3.345-fold (P < 0.010) increased compared with pregnant women with their second birth. Moreover, the chance (risk) of developing PPD in pregnant women with anxiety was 2.423-fold (P = 0.043) increased compared with pregnant women without anxiety, and the chance (risk) of developing PPD in pregnant women with depression was 3.063-fold (P = 0.005) increased compared with women without depression. Table 3 presents the stratified analyses of all variables to identify the fold increase in the risk of developing PPD in pregnant women with SD compared www.oncotarget.com with pregnant women without SD. In the population of pregnant women aged 21-30 years after other factors were controlled, the chance (risk) of developing PPD in patients with SD was 8.593-fold (P = 0.001) increased compared with pregnant women without SD. In the population of pregnant women aged 31-34 years, the chance (risk) of developing PPD in patients with SD was 5.911-fold (P = 0.027) increased compared with pregnant women without SD. Among pregnant women with their first-time birth, the risk of developing PPD in patients with SD was 10.098-fold (P < 0.011) increased compared with pregnant women without SD. Table 4 presents the stratified analyses on postpartum time (≤ 6 weeks, 6-12 weeks, and > 12 weeks). Regardless of postpartum time (≤ 6 weeks, 6-12 weeks, and > 12 weeks), the risks of developing PPD in pregnant women with SD were increased, by 5.461-fold (P < 0.001), 3.490-fold (P = 0.010), and 3.416-fold (P = 0.015), respectively, compared with pregnant women without SD. Figure 3 presents the cross analyses of pregnancy parity and postpartum time. The risk of developing PPD in pregnant women with their first-time pregnancy within postpartum 6 weeks was the highest and was 8.174-fold increased compared with pregnant women with their second (or greater) pregnancy at postpartum 12 weeks (or longer).
DISCUSSION
SD are a risk factor for developing PPD in women in Taiwan. SD increased the risk of developing PPD in women (the risk in cases with SD was 5.359-fold increased compared with cases without SD). In addition, regardless of postpartum time (≤ 6 weeks, 6-12 weeks, and > 12 weeks), the chance (risk) of developing PPD was greater than 3.416-fold increased in pregnant women with SD compared with pregnant women without SD. Previous studies revealed that patients with SD are likely aware of bad health conditions or negative emotions, such as working under great stress [15, 21] . Moreover, the majority of studies also indicate that pregnant women are under great stress with their first birth due to physical and mental changes, expectations of newborns, and uncertainty of family and social welfare support [22] . As a result, this study demonstrates that pregnant women experiencing their first birth exhibit increased risks of developing PPD. Reduced sleep quality during pregnancy might be an important risk factor for developing PPD. Therefore, persistent relief of SD is very important.
SD are a defined as difficulty falling asleep, light sleep, and frequent periods of being awake at night with symptoms persisting for at least one month. SD are a common disease and can affect the quality of life of a normal individual [23] . Most current articles focus on the association between SD and pressure, shift work, and reproductive dysfunction as study topics [24] [25] [26] [27] but did not perform a similar analysis on the risk of developing PPD caused by SD. This study was the first study in Taiwan relevant to this topic.
Previous studies noted that poor sleep quality was highly associated with depression [28, 29] . In addition, some studies investigated the development of mood disorders in pregnant women during the postpartum period using the Pittsburgh Sleep Quality Index. Poor sleep quality in late pregnancy increased the risk of depression recurrence. In particular, poor subjective sleep quality was highly associated with PPD symptoms [14, 30] . Furthermore, some scholars utilized wrist actigraphy and self-report surveys to study the association between sleep quality and PPD symptoms using longitudinal study surveys. The results revealed that poor sleep quality could be a risk factor for developing PPD and demonstrated that poor sleep quality in women in the early postpartum period was associated with symptoms of depression [31] . The above study results were similar to those in this study. Data in this study even indicated that SD increased the risk of developing PPD (regardless of postpartum time) and could be further used as an assessment item in the prenatal examinations of pregnant women.
This study demonstrated that among pregnant women with SD, the risk of developing PPD was the highest in pregnant women experiencing their first birth sleep conditions of women experiencing their first birth and less than 25 years of age should be actively assessed to reduce the risk of developing PPD.
In addition, this study demonstrated that the risk of developing PPD in pregnant women with a history of depression was 3.063-fold increased compared with women without a history of this disease. These results were similar to those in studies in other countries demonstrating that SD in late pregnancy increased the recurrence of postpartum major depression (PPMD), especially in cases with a history of major depression [14] . The possible reason for this finding was that pregnant women in early pregnancy already began to experience different challenges of pregnancy and were persistently subjected to various pressures. If depression developed before pregnancy, the possibility of developing PPD greatly increased. In addition, poor sleep quality in late pregnancy was associated with recurrence. Furthermore, this study revealed another phenomenon: the risk of developing PPD in pregnant women with a history of anxiety was 2.423-fold increased compared with pregnant women without a history of anxiety. However, no relevant study is available for comparison in Taiwan or other countries; thus, further studies in this field should be performed.
This study has the following limitations. First, the health insurance data do not include the variable of the severity of SD. Therefore, relevant data are not available to discuss the severity of SD. Second, the associations between social demographic factors, such as age, number of births, and disease history, and PPD were analyzed. However, other psychological and social variables, such as potential influencing factors including the family support level and the education level of the pregnant women, might also affect PPD; however, these variables could not be further investigated in this study.
MATERIALS AND METHODS

Data sources
This study performed analyses using data from the NHIRD of Taiwan from between January 1, 2000 and December 31, 2010. National health insurance was implemented in Taiwan in 1995. The NHIRD records the medical information of all insured, with a coverage rate of greater than 99% of the Taiwanese population. Therefore, we obtained data from the NHIRD to investigate the association between SD and PPD during this 10- Table 3 .; CI = confidence interval. Table 3 .; CI = confidence interval.
year period. The diagnosis used in the NHIRD is the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).
Study design and participant sampling
This study adopted the follow-up study design. New cases of pregnant women who were diagnosed with SD during pregnancy in the database were screened and selected as the study subjects in the study subject group. The study period was between January 1, 2000 and December 31, 2010. For comparison with the subject group, a control group with twice the number of subjects as the subject group with matched age, income, and number of births was selected (pregnant women without a diagnosis of SD). Table 3 Interaction (Times of postpartum × Number of births) P < 0.001. www.oncotarget.com
Occurrence
All study participants were observed from the beginning of pregnancy until the development of PPD (ICD-9-CM 648.4) or until the end of this study on December 31, 2010.
Age and comorbidities
Study subjects were divided into 6 age groups (≤ 20 years, 21-30 years, 31-34 years, 35-37 years, 38-40 years, and ≥ 41 years). Comorbidities included hypertension (ICD-9-CM: 401-405), diabetes mellitus (DM; ICD-9-CM: 250), hyperlipidemia (ICD-9-CM: 272), chronic obstructive pulmonary disease (COPD; ICD-9-CM: 490-496), chronic kidney disease (CKD; ICD-9-CM: 585), ischemic heart disease (IHD; ICD-9-CM:410-414), congestive heart disease (CHD; ICD-9-CM:428-429), stroke (ICD-9-CM: 430-438), cancer (ICD-9-CM: 140-208), anxiety (ICD-9-CM: 300.00), and depression (ICD-9-CM 296.2-296.3, 300.4).
Statistical analyses
All analyses were performed using SPSS 22 software (SPSS, Inc., Chicago, IL, USA). Basic descriptive statistics included percentage, mean value, and standard deviation. Relevant study variables included age, urbanization, income, season, comorbidity, and number of births. In addition, comparisons of categorical variables (with and without SD) were performed using the Χ 2 test. The differences between two groups were expressed using the hazard ratio (HR) and 95% confidence interval (CI). P < 0.05 was used as the standard for determining significance.
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